Stock Research for APRI

APRI
Current Price

$1.0263


Latest Update: 2018-02-23 16:00:00

High
$ 1.0263
Low
$ 1.0200
Close
$ 1.0200
Volume
1359
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

APRI Stock Chart & Research Data

The APRI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the APRI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


APRI Due diligence Resources & Stock Charts

The APRI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View APRI Detailed Price Forecast - CNN Money CNN View APRI Detailed Summary - Google Finance
Yahoo View APRI Detailed Summary - Yahoo! Finance Zacks View APRI Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View APRI Trends & Analysis - Trade-Ideas Barrons View APRI Major Holders - Barrons
NASDAQ View APRI Call Transcripts - NASDAQ Seeking View APRI Breaking News & Analysis - Seeking Alpha
Spotlight View APRI Annual Report - CompanySpotlight.com OTC Report View APRI OTC Short Report - OTCShortReport.com
TradeKing View APRI Fundamentals - TradeKing Charts View APRI SEC Filings - Bar Chart
WSJ View Historical Prices for APRI - The WSJ Morningstar View Performance/Total Return for APRI - Morningstar
MarketWatch View the Analyst Estimates for APRI - MarketWatch CNBC View the Earnings History for APRI - CNBC
StockMarketWatch View the APRI Earnings - StockMarketWatch MacroAxis View APRI Buy or Sell Recommendations - MacroAxis
Bullish View the APRI Bullish Patterns - American Bulls Short Pains View APRI Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View APRI Stock Mentions - StockTwits PennyStocks View APRI Stock Mentions - PennyStockTweets
Twitter View APRI Stock Mentions - Twitter Invest Hub View APRI Investment Forum News - Investor Hub
Yahoo View APRI Stock Mentions - Yahoo! Message Board Seeking Alpha View APRI Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for APRI - SECform4.com Insider Cow View Insider Transactions for APRI - Insider Cow
CNBC View APRI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for APRI - OTC Markets
Yahoo View Insider Transactions for APRI - Yahoo! Finance NASDAQ View Institutional Holdings for APRI - NASDAQ


Stock Charts

FinViz View APRI Stock Insight & Charts - FinViz.com StockCharts View APRI Investment Charts - StockCharts.com
BarChart View APRI Stock Overview & Charts - BarChart Trading View View APRI User Generated Charts - Trading View


Latest Financial News for APRI

Apricus Biosciences (APRI) Soars: Stock Adds 8.6% in Session
Posted on Wednesday February 21, 2018

Shares of Apricus Biosciences (APRI) rose about 9% yesterday.


Apricus Biosciences Announces Corporate Update, Fourth Quarter and Full Year 2017 Financial Results Conference Call
Posted on Wednesday February 21, 2018

SAN DIEGO, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that the Company`s ...


Here’s What’s Moving Apricus Biosciences And Pacira Pharmaceuticals
Posted on Tuesday February 20, 2018

Apricus Biosciences, Inc. (NASDAQ:APRI) is an early mover in the biotechnology space this week, with the company putting out an update on a regulatory development from its lead development asset. Unfortunately, for both the company and its shareholders, the update lands squarely on the negative end of the spectrum. So what happened? Apricus just reported […] The post Here’s What’s Moving Apricus Biosciences And Pacira Pharmaceuticals appeared first on Market Exclusive.


What's Next For Apricus Biosciences' Vitaros?
Posted on Tuesday February 20, 2018

Apricus Biosciences Inc (NASDAQ: APRI ) receded 67.4 percent Friday and continued down Tuesday after the U.S. Food and Drug Administration issued a response letter for Vitaros. The FDA declined to approve ...


Apricus Biosciences Announces Corporate Update, Fourth Quarter and Full Year ...
GlobeNewswire (press release) - Feb 21, 2018
SAN DIEGO, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that the Company's fourth quarter and full year 2017 financial ...
What's Next For Apricus Biosciences' Vitaros? - Benzinga
Does Apricus Biosciences Inc's (NASDAQ:APRI) Past Performance Indicate A ... - Simply Wall St

Apricus Biosciences Receives Complete Response Letter from FDA for Vitaros™
GlobeNewswire (press release) - Feb 16, 2018
Apricus Biosciences, Inc. (APRI) is a biopharmaceutical company advancing innovative medicines in urology and rheumatology.
Apricus Biosciences Gets CRL From FDA For Vitaros - Nasdaq
Is It “Game Over” After Apricus Biosciences Inc (APRI) FDA Rejection? - Smarter Analyst

Another February Biotech Catalyst To Watch
Seeking Alpha - Feb 7, 2018
On Jan. 31, I published an article on three biotech catalysts to watch in February; this article adds another one to the list. On Feb. 17, Apricus Biosciences will get the FDA verdict on Vitaros, a topical cream for the treatment of erectile ...

Active Mover: Apricus Biosciences Inc (NASDAQ: APRI)
Alpha Beta Stock - 8 hours ago
U.S. stocks rose on Friday but were still on track to post weekly losses. Wall Street also looked ahead to the release of the Federal Reserve's monetary policy report.
Apricus Biosciences (APRI) Downgraded by Zacks Investment Research to “Sell” - StockNewsTimes
Apricus Biosciences, Inc. (APRI) is expected to report earnings of $-0.15 a ... - StandardOracle

Enter a stock symbol to view the stock details.